OneMedNet has partnered with ViuHealth to integrate ViuHealth’s longitudinal autoimmune disease dataset into the iRWD platform powered by Palantir Foundry, enhancing scale, diversity, and longitudinal depth of autoimmune real-world data for regulatory, AI model development, HEOR, and other use cases.

The partnership advances OneMedNet’s subscription license strategy by offering enriched, disease-specific longitudinal datasets to pharma and biotech firms, supporting drug discovery, label expansions, and pricing or reimbursement analyses. This aligns with the company’s recurring revenue model, following prior reported 815% year-over-year bookings growth and a 4.5X increase in inbound demand.

The global autoimmune therapeutics market is valued at $166 billion, driven by chronic condition prevalence and demand for deep real-world insights. ViuHealth’s ongoing contributions of patient journeys, treatment adherence, flares, and outcomes data aim to accelerate R&D timelines, inform regulatory evidence, and optimize market positioning for therapy developers.